Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOFOSBUVIR vs SOLRIAMFETOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SOFOSBUVIR vs SOLRIAMFETOL: Safety Overview

Metric SOFOSBUVIR SOLRIAMFETOL
Total FAERS Reports 17,291 2,135
Deaths Reported 1,642 9
Death Rate 9.5% 0.4%
Hospitalizations 4,103 75
Average Patient Age 57.9 yrs 43.2 yrs
% Female Patients 38.4% 71.4%
FDA Approval Date Aug 28, 2019 Jun 17, 2019
Manufacturer Gilead Sciences, Inc. Axsome Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription